U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298642) titled 'Extended-field Proton Therapy for Cervical Cancer' on Nov. 26.
Brief Summary: Severe lymphopenia is a common complication of extended-field radiotherapy in cervical cancer, significantly impacting immune function and clinical outcomes. This study aims to evaluate whether proton therapy, with its superior dose distribution, can reduce lymphopenia and improve survival and toxicity profiles compared to photon therapy.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Cervical Cancer
Intervention:
RADIATION: Proton extended field radiation therapy
Proton extended field radiation therapy
RADIATION: Photon extended ...